Novartis Ag (NVSEF) Non-Current Assets (2009 - 2025)

Novartis Ag has disclosed Non-Current Assets across 12 years of filings, most recently posting $80.5 billion for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $80.5 billion, up 10.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $80.5 billion (up 10.96% YoY), and the FY2025 annual result was $80.5 billion, up 10.96% from the prior year.
• Non-Current Assets came in at $80.5 billion for Q4 2025 at Novartis Ag, up from $78.5 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $86.1 billion in Q4 2021 to a low of $57.5 billion in Q2 2021.
• The 5-year median for Non-Current Assets is $78.0 billion (2023), against an average of $75.9 billion.
• Across the five-year window, Non-Current Assets jumped 47.42% in 2022 and retreated 13.76% in 2023, its largest moves.
• Novartis Ag's Non-Current Assets stood at $86.1 billion in 2021, then decreased by 6.43% to $80.5 billion in 2022, then declined by 13.76% to $69.5 billion in 2023, then climbed by 4.43% to $72.5 billion in 2024, then gained by 10.96% to $80.5 billion in 2025.
• The last three Non-Current Assets figures came in at $80.5 billion (Q4 2025), $78.5 billion (Q2 2025), and $72.5 billion (Q4 2024), per Business Quant data.